- Home
- KVHI vs RAPT Comparison
KVHI vs RAPT Comparison
Compare KVHI & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- RAPT
- Stock Information
- Founded
- KVHI 1978
- RAPT 2015
- Country
- KVHI United States
- RAPT United States
- Employees
- KVHI N/A
- RAPT N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- RAPT Health Care
- Exchange
- KVHI Nasdaq
- RAPT Nasdaq
- Market Cap
- KVHI 100.2M
- RAPT 117.5M
- IPO Year
- KVHI 1996
- RAPT 2019
- Fundamental
- Price
- KVHI $5.05
- RAPT $0.75
- Analyst Decision
- KVHI
- RAPT Hold
- Analyst Count
- KVHI 0
- RAPT 7
- Target Price
- KVHI N/A
- RAPT $5.00
- AVG Volume (30 Days)
- KVHI 23.7K
- RAPT 829.4K
- Earning Date
- KVHI 05-07-2025
- RAPT 05-08-2025
- Dividend Yield
- KVHI N/A
- RAPT N/A
- EPS Growth
- KVHI N/A
- RAPT N/A
- EPS
- KVHI N/A
- RAPT N/A
- Revenue
- KVHI $109,975,000.00
- RAPT N/A
- Revenue This Year
- KVHI $4.22
- RAPT N/A
- Revenue Next Year
- KVHI $13.27
- RAPT N/A
- P/E Ratio
- KVHI N/A
- RAPT N/A
- Revenue Growth
- KVHI N/A
- RAPT N/A
- 52 Week Low
- KVHI $4.17
- RAPT $0.75
- 52 Week High
- KVHI $6.16
- RAPT $8.58
- Technical
- Relative Strength Index (RSI)
- KVHI 49.14
- RAPT 33.73
- Support Level
- KVHI $4.93
- RAPT $0.75
- Resistance Level
- KVHI $5.26
- RAPT $0.85
- Average True Range (ATR)
- KVHI 0.19
- RAPT 0.08
- MACD
- KVHI 0.02
- RAPT -0.00
- Stochastic Oscillator
- KVHI 44.19
- RAPT 0.97
About KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.